Publications
Study tested the a priori hypothesis that amantadine reduces irritability (primary hypothesis) and aggression (secondary hypothesis) among individuals with chronic traumatic brain injury (TBI). A total of 76 individuals greater than 6 months post-TBI were randomly assigned to receive 100 milligrams of amantadine hydrochloride twice a day or an ...